Multicenter prospective study on the changes of sexual function following treatment with alfuzosin (Xatral XL) in patients with benign prostatic hypertrophy.

Trial Profile

Multicenter prospective study on the changes of sexual function following treatment with alfuzosin (Xatral XL) in patients with benign prostatic hypertrophy.

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Mar 2010

At a glance

  • Drugs Alfuzosin (Primary)
  • Indications Benign prostatic hyperplasia; Lower urinary tract symptoms
  • Focus Therapeutic Use
  • Sponsors Sanofi
  • Most Recent Events

    • 24 Oct 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top